|
|
cellular response to dna damage stimulus
|
GO:0006974 |
207 |
0.590
|
Human |
|
|
protein modification by small protein conjugation or removal
|
GO:0070647 |
207 |
0.338
|
Human |
|
|
macromolecule catabolic process
|
GO:0009057 |
281 |
0.326
|
Human |
|
|
protein catabolic process
|
GO:0030163 |
221 |
0.295
|
Human |
|
|
spermatid differentiation
|
GO:0048515 |
115 |
0.284
|
|
|
|
modification dependent protein catabolic process
|
GO:0019941 |
133 |
0.270
|
Human |
|
|
spermatid development
|
GO:0007286 |
108 |
0.266
|
|
|
|
regulation of organelle organization
|
GO:0033043 |
289 |
0.261
|
Human |
|
|
small gtpase mediated signal transduction
|
GO:0007264 |
97 |
0.260
|
|
|
|
protein ubiquitination
|
GO:0016567 |
171 |
0.251
|
Human |
|
|
organelle assembly
|
GO:0070925 |
177 |
0.248
|
|
|
|
histone modification
|
GO:0016570 |
159 |
0.215
|
Human |
|
|
ubiquitin dependent protein catabolic process
|
GO:0006511 |
129 |
0.176
|
Human |
|
|
modification dependent macromolecule catabolic process
|
GO:0043632 |
133 |
0.171
|
Human |
|
|
spermatogenesis
|
GO:0007283 |
284 |
0.170
|
|
|
|
cytoplasmic transport
|
GO:0016482 |
234 |
0.169
|
|
|
|
dendrite development
|
GO:0016358 |
115 |
0.169
|
|
|
|
protein modification by small protein conjugation
|
GO:0032446 |
187 |
0.165
|
Human |
|
|
negative regulation of protein metabolic process
|
GO:0051248 |
282 |
0.160
|
Human |
|
|
neuron migration
|
GO:0001764 |
122 |
0.152
|
|
|
|
regulation of histone modification
|
GO:0031056 |
56 |
0.150
|
Human |
|
|
ras protein signal transduction
|
GO:0007265 |
77 |
0.148
|
|
|
|
neural tube development
|
GO:0021915 |
160 |
0.143
|
|
|
|
apoptotic signaling pathway
|
GO:0097190 |
306 |
0.133
|
|
|
|
positive regulation of protein modification process
|
GO:0031401 |
299 |
0.132
|
|
|
|
mitotic cell cycle
|
GO:0000278 |
195 |
0.131
|
|
|
|
mitotic cell cycle process
|
GO:1903047 |
159 |
0.131
|
|
|
|
negative regulation of immune system process
|
GO:0002683 |
209 |
0.115
|
|
|
|
chromatin modification
|
GO:0016568 |
187 |
0.111
|
Human |
|
|
regionalization
|
GO:0003002 |
337 |
0.107
|
|
|
|
regulation of cell projection organization
|
GO:0031344 |
206 |
0.094
|
|
|
|
stem cell development
|
GO:0048864 |
219 |
0.094
|
|
|
|
covalent chromatin modification
|
GO:0016569 |
163 |
0.093
|
Human |
|
|
regulation of cellular response to stress
|
GO:0080135 |
159 |
0.093
|
Human |
|
|
posttranscriptional regulation of gene expression
|
GO:0010608 |
155 |
0.093
|
|
|
|
male gamete generation
|
GO:0048232 |
285 |
0.091
|
|
|
|
purine containing compound metabolic process
|
GO:0072521 |
311 |
0.090
|
|
|
|
microtubule cytoskeleton organization
|
GO:0000226 |
157 |
0.090
|
|
|
|
regulation of cellular component size
|
GO:0032535 |
121 |
0.085
|
|
|
|
regulation of neuron projection development
|
GO:0010975 |
169 |
0.084
|
|
|
|
protein localization to organelle
|
GO:0033365 |
185 |
0.084
|
|
|
|
regulation of neuron differentiation
|
GO:0045664 |
281 |
0.082
|
|
|
|
regulation of apoptotic signaling pathway
|
GO:2001233 |
197 |
0.080
|
|
|
|
negative regulation of cellular protein metabolic process
|
GO:0032269 |
247 |
0.080
|
Human |
|
|
rhythmic process
|
GO:0048511 |
174 |
0.080
|
|
|
|
cellular protein catabolic process
|
GO:0044257 |
155 |
0.079
|
Human |
|
|
guanosine containing compound metabolic process
|
GO:1901068 |
144 |
0.076
|
|
|
|
germ cell development
|
GO:0007281 |
185 |
0.074
|
|
|
|
purine nucleoside metabolic process
|
GO:0042278 |
241 |
0.073
|
|
|
|
negative regulation of molecular function
|
GO:0044092 |
258 |
0.072
|
|
|
|
regulation of establishment of protein localization
|
GO:0070201 |
181 |
0.071
|
|
|
|
proteolysis involved in cellular protein catabolic process
|
GO:0051603 |
147 |
0.071
|
Human |
|
|
compound eye development
|
GO:0048749 |
1 |
0.070
|
|
|
|
organonitrogen compound catabolic process
|
GO:1901565 |
264 |
0.069
|
|
|
|
regulation of protein complex assembly
|
GO:0043254 |
83 |
0.068
|
|
|
|
regulation of nucleocytoplasmic transport
|
GO:0046822 |
73 |
0.068
|
|
|
|
cellular ketone metabolic process
|
GO:0042180 |
84 |
0.067
|
|
|
|
ribose phosphate metabolic process
|
GO:0019693 |
291 |
0.067
|
|
|
|
organophosphate catabolic process
|
GO:0046434 |
232 |
0.066
|
|
|
|
embryonic epithelial tube formation
|
GO:0001838 |
130 |
0.066
|
|
|
|
cellular macromolecule catabolic process
|
GO:0044265 |
206 |
0.065
|
Human |
|
|
regulation of chromatin organization
|
GO:1902275 |
57 |
0.065
|
Human |
|
|
negative regulation of cellular component organization
|
GO:0051129 |
194 |
0.065
|
Human |
|
|
maintenance of location
|
GO:0051235 |
89 |
0.065
|
|
|
|
regulation of transferase activity
|
GO:0051338 |
263 |
0.064
|
|
|
|
microtubule based process
|
GO:0007017 |
236 |
0.064
|
|
|
|
nucleoside triphosphate catabolic process
|
GO:0009143 |
205 |
0.063
|
|
|
|
amine metabolic process
|
GO:0009308 |
45 |
0.062
|
|
|
|
cellular nitrogen compound catabolic process
|
GO:0044270 |
280 |
0.061
|
|
|
|
developmental maturation
|
GO:0021700 |
193 |
0.060
|
|
|
|
cell division
|
GO:0051301 |
120 |
0.060
|
|
|
|
nucleoside phosphate catabolic process
|
GO:1901292 |
222 |
0.060
|
|
|
|
positive regulation of organelle organization
|
GO:0010638 |
128 |
0.059
|
|
|
|
regulation of cellular amino acid metabolic process
|
GO:0006521 |
5 |
0.059
|
|
|
|
stem cell differentiation
|
GO:0048863 |
268 |
0.059
|
|
|
|
negative regulation of cell proliferation
|
GO:0008285 |
296 |
0.059
|
|
|
|
transforming growth factor beta receptor signaling pathway
|
GO:0007179 |
71 |
0.059
|
|
|
|
ribonucleotide metabolic process
|
GO:0009259 |
291 |
0.059
|
|
|
|
nucleotide metabolic process
|
GO:0009117 |
332 |
0.058
|
|
|
|
aromatic compound catabolic process
|
GO:0019439 |
286 |
0.057
|
|
|
|
endocytosis
|
GO:0006897 |
168 |
0.057
|
|
|
|
development of primary sexual characteristics
|
GO:0045137 |
143 |
0.057
|
|
|
|
purine nucleotide metabolic process
|
GO:0006163 |
302 |
0.057
|
|
|
|
regulation of intracellular transport
|
GO:0032386 |
159 |
0.055
|
|
|
|
ribonucleoside triphosphate metabolic process
|
GO:0009199 |
220 |
0.055
|
|
|
|
neural tube closure
|
GO:0001843 |
90 |
0.055
|
|
|
|
regulation of cytoskeleton organization
|
GO:0051493 |
122 |
0.054
|
|
|
|
positive regulation of protein phosphorylation
|
GO:0001934 |
242 |
0.053
|
|
|
|
apical constriction
|
GO:0003383 |
4 |
0.053
|
|
|
|
organic cyclic compound catabolic process
|
GO:1901361 |
295 |
0.053
|
|
|
|
regulation of cell cycle
|
GO:0051726 |
281 |
0.053
|
|
|
|
negative regulation of intracellular signal transduction
|
GO:1902532 |
167 |
0.052
|
|
|
|
ribonucleotide catabolic process
|
GO:0009261 |
208 |
0.052
|
|
|
|
cellular response to lipid
|
GO:0071396 |
145 |
0.052
|
|
|
|
cellular response to growth factor stimulus
|
GO:0071363 |
197 |
0.051
|
|
|
|
response to growth factor
|
GO:0070848 |
198 |
0.051
|
|
|
|
actin filament organization
|
GO:0007015 |
113 |
0.051
|
|
|
|
digestive tract morphogenesis
|
GO:0048546 |
147 |
0.051
|
|
|
|
intracellular steroid hormone receptor signaling pathway
|
GO:0030518 |
29 |
0.051
|
|
|
|
organelle fission
|
GO:0048285 |
170 |
0.050
|
|
|
|
dna repair
|
GO:0006281 |
107 |
0.049
|
Human |
|
|
microtubule organizing center organization
|
GO:0031023 |
28 |
0.049
|
|
|
|
metal ion homeostasis
|
GO:0055065 |
189 |
0.049
|
|
|
|
purine nucleoside triphosphate catabolic process
|
GO:0009146 |
203 |
0.048
|
|
|
|
intracellular protein transport
|
GO:0006886 |
204 |
0.047
|
|
|
|
chromatin organization
|
GO:0006325 |
206 |
0.047
|
Human |
|
|
wnt signaling pathway
|
GO:0016055 |
188 |
0.047
|
|
|
|
establishment of organelle localization
|
GO:0051656 |
122 |
0.047
|
|
|
|
dna metabolic process
|
GO:0006259 |
303 |
0.046
|
Human |
|
|
stem cell maintenance
|
GO:0019827 |
130 |
0.046
|
|
|
|
heterocycle catabolic process
|
GO:0046700 |
280 |
0.046
|
|
|
|
transmembrane receptor protein tyrosine kinase signaling pathway
|
GO:0007169 |
247 |
0.045
|
|
|
|
regulation of response to dna damage stimulus
|
GO:2001020 |
34 |
0.045
|
Human |
|
|
cell type specific apoptotic process
|
GO:0097285 |
268 |
0.045
|
|
|
|
organelle localization
|
GO:0051640 |
179 |
0.045
|
|
|
|
purine ribonucleoside triphosphate metabolic process
|
GO:0009205 |
220 |
0.045
|
|
|
|
nucleoside catabolic process
|
GO:0009164 |
206 |
0.044
|
|
|
|
protein autophosphorylation
|
GO:0046777 |
61 |
0.044
|
|
|
|
nucleoside phosphate metabolic process
|
GO:0006753 |
338 |
0.044
|
|
|
|
oocyte axis specification
|
GO:0007309 |
2 |
0.044
|
|
|
|
cilium assembly
|
GO:0042384 |
81 |
0.043
|
|
|
|
smoothened signaling pathway
|
GO:0007224 |
105 |
0.043
|
|
|
|
glycosyl compound metabolic process
|
GO:1901657 |
246 |
0.043
|
|
|
|
cell adhesion
|
GO:0007155 |
329 |
0.043
|
|
|
|
digestive tract development
|
GO:0048565 |
190 |
0.042
|
|
|
|
cell substrate adhesion
|
GO:0031589 |
130 |
0.042
|
|
|
|
glycerophospholipid metabolic process
|
GO:0006650 |
71 |
0.041
|
|
|
|
positive regulation of intracellular transport
|
GO:0032388 |
70 |
0.041
|
|
|
|
negative regulation of phosphorylation
|
GO:0042326 |
166 |
0.041
|
|
|
|
gastrulation
|
GO:0007369 |
116 |
0.041
|
|
|
|
protein maturation
|
GO:0051604 |
176 |
0.041
|
|
|
|
circadian rhythm
|
GO:0007623 |
114 |
0.041
|
|
|
|
protein deubiquitination
|
GO:0016579 |
19 |
0.040
|
|
|
|
positive regulation of chromatin modification
|
GO:1903310 |
28 |
0.039
|
|
|
|
digestive system development
|
GO:0055123 |
200 |
0.039
|
|
|
|
regulation of cell migration
|
GO:0030334 |
219 |
0.039
|
|
|
|
epithelial tube formation
|
GO:0072175 |
130 |
0.039
|
|
|
|
membrane organization
|
GO:0061024 |
245 |
0.039
|
|
|
|
regulation of cellular ketone metabolic process
|
GO:0010565 |
66 |
0.038
|
|
|
|
actin filament based movement
|
GO:0030048 |
23 |
0.038
|
|
|
|
cellular amine metabolic process
|
GO:0044106 |
44 |
0.037
|
|
|
|
actin cytoskeleton organization
|
GO:0030036 |
220 |
0.037
|
|
|
|
regulation of chromatin silencing
|
GO:0031935 |
2 |
0.037
|
|
|
|
negative regulation of phosphorus metabolic process
|
GO:0010563 |
184 |
0.037
|
|
|
|
morphogenesis of embryonic epithelium
|
GO:0016331 |
159 |
0.037
|
|
|
|
intracellular receptor signaling pathway
|
GO:0030522 |
74 |
0.037
|
|
|
|
myeloid cell differentiation
|
GO:0030099 |
233 |
0.037
|
|
|
|
proteasomal protein catabolic process
|
GO:0010498 |
98 |
0.036
|
|
|
|
neural tube formation
|
GO:0001841 |
108 |
0.036
|
|
|
|
purine ribonucleotide catabolic process
|
GO:0009154 |
208 |
0.036
|
|
|
|
neuron death
|
GO:0070997 |
154 |
0.036
|
|
|
|
purine nucleotide catabolic process
|
GO:0006195 |
211 |
0.035
|
|
|
|
protein polyubiquitination
|
GO:0000209 |
33 |
0.035
|
Human |
|
|
protein processing
|
GO:0016485 |
163 |
0.035
|
|
|
|
protein deacetylation
|
GO:0006476 |
32 |
0.035
|
|
|
|
glycerolipid metabolic process
|
GO:0046486 |
122 |
0.035
|
|
|
|
transmembrane receptor protein serine threonine kinase signaling pathway
|
GO:0007178 |
194 |
0.034
|
|
|
|
tube closure
|
GO:0060606 |
91 |
0.034
|
|
|
|
positive regulation of nervous system development
|
GO:0051962 |
221 |
0.034
|
|
|
|
regulation of hydrolase activity
|
GO:0051336 |
246 |
0.034
|
|
|
|
proteasome mediated ubiquitin dependent protein catabolic process
|
GO:0043161 |
88 |
0.034
|
|
|
|
nuclear transport
|
GO:0051169 |
139 |
0.033
|
|
|
|
regulation of cell motility
|
GO:2000145 |
236 |
0.033
|
|
|
|
nucleus localization
|
GO:0051647 |
20 |
0.033
|
|
|
|
purine ribonucleotide metabolic process
|
GO:0009150 |
290 |
0.033
|
|
|
|
histone lysine methylation
|
GO:0034968 |
50 |
0.032
|
|
|
|
mapk cascade
|
GO:0000165 |
281 |
0.032
|
|
|
|
regulation of cell activation
|
GO:0050865 |
289 |
0.032
|
|
|
|
purine nucleoside triphosphate metabolic process
|
GO:0009144 |
226 |
0.032
|
|
|
|
nucleoside metabolic process
|
GO:0009116 |
246 |
0.031
|
|
|
|
gland development
|
GO:0048732 |
330 |
0.031
|
|
|
|
blastocyst development
|
GO:0001824 |
80 |
0.031
|
|
|
|
epithelial cell development
|
GO:0002064 |
159 |
0.031
|
|
|
|
olfactory learning
|
GO:0008355 |
2 |
0.031
|
|
|
|
response to transforming growth factor beta
|
GO:0071559 |
88 |
0.031
|
|
|
|
regulation of proteolysis
|
GO:0030162 |
164 |
0.031
|
|
|
|
cellularization
|
GO:0007349 |
1 |
0.030
|
|
|
|
body morphogenesis
|
GO:0010171 |
45 |
0.030
|
|
|
|
regulation of protein stability
|
GO:0031647 |
52 |
0.030
|
|
|
|
regulation of cytoplasmic transport
|
GO:1903649 |
112 |
0.030
|
|
|
|
mitotic cytokinesis
|
GO:0000281 |
4 |
0.030
|
|
|
|
protein targeting
|
GO:0006605 |
143 |
0.030
|
|
|
|
ribonucleoside metabolic process
|
GO:0009119 |
245 |
0.030
|
|
|
|
lateral inhibition
|
GO:0046331 |
1 |
0.029
|
|
|
|
cellular response to transforming growth factor beta stimulus
|
GO:0071560 |
88 |
0.029
|
|
|
|
heart morphogenesis
|
GO:0003007 |
178 |
0.029
|
|
|
|
purine nucleoside catabolic process
|
GO:0006152 |
205 |
0.029
|
|
|
|
positive regulation of cell development
|
GO:0010720 |
237 |
0.029
|
|
|
|
positive regulation of dna templated transcription elongation
|
GO:0032786 |
2 |
0.029
|
|
|
|
exocytosis
|
GO:0006887 |
121 |
0.029
|
|
|
|
inorganic cation transmembrane transport
|
GO:0098662 |
207 |
0.029
|
|
|
|
peptidyl amino acid modification
|
GO:0018193 |
336 |
0.029
|
|
|
|
guanosine containing compound catabolic process
|
GO:1901069 |
144 |
0.029
|
|
|
|
regulation of ras protein signal transduction
|
GO:0046578 |
114 |
0.029
|
|
|
|
developmental growth involved in morphogenesis
|
GO:0060560 |
138 |
0.029
|
|
|
|
carbohydrate derivative catabolic process
|
GO:1901136 |
231 |
0.028
|
|
|
|
regulation of lymphocyte activation
|
GO:0051249 |
240 |
0.028
|
|
|
|
regulation of wnt signaling pathway
|
GO:0030111 |
123 |
0.028
|
|
|
|
response to organic cyclic compound
|
GO:0014070 |
198 |
0.028
|
|
|
|
cell growth
|
GO:0016049 |
130 |
0.028
|
|
|
|
positive regulation of cellular amine metabolic process
|
GO:0033240 |
5 |
0.028
|
|
|
|
meiotic cell cycle process
|
GO:1903046 |
77 |
0.027
|
|
|
|
regulation of mapk cascade
|
GO:0043408 |
248 |
0.027
|
|
|
|
negative regulation of lymphocyte activation
|
GO:0051250 |
91 |
0.027
|
|
|
|
metencephalon development
|
GO:0022037 |
89 |
0.027
|
|
|
|
locomotor rhythm
|
GO:0045475 |
8 |
0.027
|
|
|
|
positive regulation of kinase activity
|
GO:0033674 |
155 |
0.027
|
|
|
|
chromatin silencing
|
GO:0006342 |
15 |
0.026
|
|
|
|
cellular component assembly involved in morphogenesis
|
GO:0010927 |
139 |
0.026
|
|
|
|
regulation of cellular amine metabolic process
|
GO:0033238 |
20 |
0.026
|
|
|
|
actin mediated cell contraction
|
GO:0070252 |
15 |
0.026
|
|
|
|
macromolecule deacylation
|
GO:0098732 |
37 |
0.026
|
|
|
|
positive regulation of protein kinase activity
|
GO:0045860 |
144 |
0.026
|
|
|
|
establishment of protein localization to organelle
|
GO:0072594 |
118 |
0.026
|
|
|
|
regulation of cellular component biogenesis
|
GO:0044087 |
181 |
0.026
|
|
|
|
purine containing compound catabolic process
|
GO:0072523 |
213 |
0.026
|
|
|
|
response to lipopolysaccharide
|
GO:0032496 |
128 |
0.026
|
|
|
|
rna interference
|
GO:0016246 |
2 |
0.026
|
|
|
|
camera type eye development
|
GO:0043010 |
266 |
0.026
|
|
|
|
nucleotide catabolic process
|
GO:0009166 |
217 |
0.025
|
|
|
|
cerebellar cortex morphogenesis
|
GO:0021696 |
32 |
0.025
|
|
|
|
microtubule based movement
|
GO:0007018 |
84 |
0.025
|
|
|
|
histone deacetylation
|
GO:0016575 |
26 |
0.025
|
|
|
|
meiosis i
|
GO:0007127 |
60 |
0.025
|
|
|
|
regulation of actin cytoskeleton organization
|
GO:0032956 |
84 |
0.025
|
|
|
|
positive regulation of apoptotic signaling pathway
|
GO:2001235 |
95 |
0.025
|
|
|
|
regulation of smoothened signaling pathway
|
GO:0008589 |
58 |
0.025
|
|
|
|
phagocytosis
|
GO:0006909 |
66 |
0.025
|
|
|
|
tube formation
|
GO:0035148 |
140 |
0.024
|
|
|
|
sensory system development
|
GO:0048880 |
3 |
0.024
|
|
|
|
purine ribonucleoside metabolic process
|
GO:0046128 |
241 |
0.024
|
|
|
|
gene silencing
|
GO:0016458 |
38 |
0.024
|
|
|
|
regulation of embryonic development
|
GO:0045995 |
71 |
0.024
|
|
|
|
cognition
|
GO:0050890 |
149 |
0.024
|
|
|
|
intrinsic apoptotic signaling pathway
|
GO:0097193 |
132 |
0.024
|
|
|
|
cellular response to biotic stimulus
|
GO:0071216 |
92 |
0.023
|
|
|
|
regulation of ossification
|
GO:0030278 |
112 |
0.023
|
|
|
|
nuclear division
|
GO:0000280 |
158 |
0.023
|
|
|
|
regulation of mitotic cell cycle
|
GO:0007346 |
126 |
0.023
|
|
|
|
regulation of innate immune response
|
GO:0045088 |
91 |
0.023
|
|
|
|
ribonucleoside triphosphate catabolic process
|
GO:0009203 |
199 |
0.023
|
|
|
|
regulation of anatomical structure size
|
GO:0090066 |
178 |
0.023
|
|
|
|
protein deacylation
|
GO:0035601 |
36 |
0.023
|
|
|
|
biomineral tissue development
|
GO:0031214 |
64 |
0.023
|
|
|
|
nucleobase containing small molecule metabolic process
|
GO:0055086 |
352 |
0.023
|
|
|
|
oocyte construction
|
GO:0007308 |
2 |
0.023
|
|
|
|
regulation of protein localization
|
GO:0032880 |
231 |
0.023
|
|
|
|
multicellular organism growth
|
GO:0035264 |
161 |
0.022
|
|
|
|
purine ribonucleoside triphosphate catabolic process
|
GO:0009207 |
199 |
0.022
|
|
|
|
regulation of cell cycle process
|
GO:0010564 |
160 |
0.022
|
|
|
|
immune effector process
|
GO:0002252 |
321 |
0.022
|
|
|
|
positive regulation of wnt signaling pathway
|
GO:0030177 |
45 |
0.022
|
|
|
|
axonogenesis
|
GO:0007409 |
274 |
0.022
|
|
|
|
regulation of t cell activation
|
GO:0050863 |
170 |
0.022
|
|
|
|
gtp metabolic process
|
GO:0046039 |
144 |
0.022
|
|
|
|
locomotory behavior
|
GO:0007626 |
195 |
0.021
|
|
|
|
learning or memory
|
GO:0007611 |
148 |
0.021
|
|
|
|
rho protein signal transduction
|
GO:0007266 |
32 |
0.021
|
|
|
|
regulation of protein deacetylation
|
GO:0090311 |
17 |
0.021
|
|
|
|
organ growth
|
GO:0035265 |
117 |
0.021
|
|
|
|
positive regulation of cell death
|
GO:0010942 |
224 |
0.021
|
|
|
|
t cell differentiation
|
GO:0030217 |
174 |
0.021
|
|
|
|
extrinsic apoptotic signaling pathway
|
GO:0097191 |
126 |
0.020
|
|
|
|
cation transport
|
GO:0006812 |
399 |
0.020
|
|
|
|
ribonucleoside catabolic process
|
GO:0042454 |
206 |
0.020
|
|
|
|
erythrocyte differentiation
|
GO:0030218 |
88 |
0.020
|
|
|
|
neuron projection guidance
|
GO:0097485 |
141 |
0.020
|
|
|
|
regulation of stress activated mapk cascade
|
GO:0032872 |
69 |
0.020
|
|
|
|
negative regulation of nervous system development
|
GO:0051961 |
156 |
0.020
|
|
|
|
endomembrane system organization
|
GO:0010256 |
147 |
0.020
|
|
|
|
nucleoside triphosphate metabolic process
|
GO:0009141 |
230 |
0.020
|
|
|
|
cellular response to organic cyclic compound
|
GO:0071407 |
87 |
0.020
|
|
|
|
meiotic cell cycle
|
GO:0051321 |
122 |
0.020
|
|
|
|
nucleocytoplasmic transport
|
GO:0006913 |
139 |
0.020
|
|
|
|
centrosome organization
|
GO:0051297 |
26 |
0.020
|
|
|
|
cell junction assembly
|
GO:0034329 |
52 |
0.020
|
|
|
|
epithelial tube morphogenesis
|
GO:0060562 |
303 |
0.020
|
|
|
|
negative regulation of phosphate metabolic process
|
GO:0045936 |
184 |
0.020
|
|
|
|
regulation of planar cell polarity pathway involved in axis elongation
|
GO:2000040 |
3 |
0.019
|
|
|
|
defense response to other organism
|
GO:0098542 |
197 |
0.019
|
|
|
|
sensory organ morphogenesis
|
GO:0090596 |
242 |
0.019
|
|
|
|
cellular amino acid metabolic process
|
GO:0006520 |
103 |
0.019
|
|
|
|
limb development
|
GO:0060173 |
166 |
0.019
|
|
|
|
positive regulation of cellular amino acid metabolic process
|
GO:0045764 |
3 |
0.019
|
|
|
|
regulation of actin filament based process
|
GO:0032970 |
99 |
0.019
|
|
|
|
regulation of defense response
|
GO:0031347 |
233 |
0.019
|
|
|
|
regulation of nucleotide metabolic process
|
GO:0006140 |
169 |
0.019
|
|
|
|
formation of primary germ layer
|
GO:0001704 |
77 |
0.019
|
|
|
|
positive regulation of erk1 and erk2 cascade
|
GO:0070374 |
47 |
0.019
|
|
|
|
protein import
|
GO:0017038 |
101 |
0.019
|
|
|
|
positive regulation of apoptotic process
|
GO:0043065 |
217 |
0.019
|
|
|
|
regulation of vesicle mediated transport
|
GO:0060627 |
139 |
0.019
|
|
|
|
hindbrain development
|
GO:0030902 |
128 |
0.019
|
|
|
|
leukocyte mediated immunity
|
GO:0002443 |
174 |
0.019
|
|
|
|
positive regulation of programmed cell death
|
GO:0043068 |
218 |
0.019
|
|
|
|
divalent inorganic cation homeostasis
|
GO:0072507 |
138 |
0.019
|
|
|
|
cytokinesis
|
GO:0000910 |
17 |
0.019
|
|
|
|
regulation of protein processing
|
GO:0070613 |
96 |
0.018
|
|
|
|
regulation of chromosome organization
|
GO:0033044 |
83 |
0.018
|
Human |
|
|
blood vessel morphogenesis
|
GO:0048514 |
285 |
0.018
|
|
|
|
forebrain development
|
GO:0030900 |
302 |
0.018
|
|
|
|
appendage development
|
GO:0048736 |
166 |
0.018
|
|
|
|
centrosome duplication
|
GO:0051298 |
16 |
0.018
|
|
|
|
regulation of kinase activity
|
GO:0043549 |
249 |
0.018
|
|
|
|
ameboidal type cell migration
|
GO:0001667 |
128 |
0.018
|
|
|
|
regulation of histone methylation
|
GO:0031060 |
30 |
0.018
|
|
|
|
rna polymerase ii transcriptional preinitiation complex assembly
|
GO:0051123 |
3 |
0.018
|
|
|
|
negative regulation of response to dna damage stimulus
|
GO:2001021 |
10 |
0.018
|
Human |
|
|
protein modification by small protein removal
|
GO:0070646 |
21 |
0.018
|
|
|
|
regulation of chromatin modification
|
GO:1903308 |
57 |
0.018
|
Human |
|
|
cellular response to abiotic stimulus
|
GO:0071214 |
56 |
0.018
|
|
|
|
fertilization
|
GO:0009566 |
127 |
0.018
|
|
|
|
positive regulation of defense response
|
GO:0031349 |
124 |
0.017
|
|
|
|
cerebellum morphogenesis
|
GO:0021587 |
42 |
0.017
|
|
|
|
positive regulation of cell motility
|
GO:2000147 |
116 |
0.017
|
|
|
|
positive regulation of mitotic metaphase anaphase transition
|
GO:0045842 |
2 |
0.017
|
|
|
|
actin polymerization or depolymerization
|
GO:0008154 |
54 |
0.017
|
|
|
|
regulation of nucleoside metabolic process
|
GO:0009118 |
130 |
0.017
|
|
|
|
embryonic organ morphogenesis
|
GO:0048562 |
276 |
0.017
|
|
|
|
response to epidermal growth factor
|
GO:0070849 |
4 |
0.017
|
|
|
|
cell matrix adhesion
|
GO:0007160 |
68 |
0.017
|
|
|
|
ubiquitin dependent smad protein catabolic process
|
GO:0030579 |
2 |
0.017
|
|
|
|
regulation of cell growth
|
GO:0001558 |
91 |
0.017
|
|
|
|
primary neural tube formation
|
GO:0014020 |
95 |
0.017
|
|
|
|
cell fate commitment
|
GO:0045165 |
210 |
0.017
|
|
|
|
carbohydrate metabolic process
|
GO:0005975 |
230 |
0.017
|
|
|
|
response to uv
|
GO:0009411 |
44 |
0.017
|
|
|
|
cardiac muscle cell contraction
|
GO:0086003 |
7 |
0.017
|
|
|
|
methylation
|
GO:0032259 |
134 |
0.017
|
|
|
|
nitrogen compound transport
|
GO:0071705 |
271 |
0.017
|
|
|
|
divalent inorganic cation transport
|
GO:0072511 |
178 |
0.017
|
|
|
|
cation transmembrane transport
|
GO:0098655 |
266 |
0.017
|
|
|
|
chromosome segregation
|
GO:0007059 |
48 |
0.016
|
|
|
|
innate immune response
|
GO:0045087 |
157 |
0.016
|
|
|
|
dendritic cell apoptotic process
|
GO:0097048 |
3 |
0.016
|
|
|
|
developmental cell growth
|
GO:0048588 |
84 |
0.016
|
|
|
|
positive regulation of cellular component biogenesis
|
GO:0044089 |
94 |
0.016
|
|
|
|
gonad development
|
GO:0008406 |
141 |
0.016
|
|
|
|
stress activated protein kinase signaling cascade
|
GO:0031098 |
81 |
0.016
|
|
|
|
regulation of myeloid cell differentiation
|
GO:0045637 |
96 |
0.016
|
|
|
|
regulation of intrinsic apoptotic signaling pathway
|
GO:2001242 |
61 |
0.016
|
|
|
|
regulation of sequence specific dna binding transcription factor activity
|
GO:0051090 |
106 |
0.016
|
|
|
|
cellular response to radiation
|
GO:0071478 |
28 |
0.016
|
|
|
|
bone development
|
GO:0060348 |
120 |
0.016
|
|
|
|
cellular protein complex assembly
|
GO:0043623 |
116 |
0.016
|
|
|
|
regulation of lymphocyte proliferation
|
GO:0050670 |
117 |
0.016
|
|
|
|
i kappab kinase nf kappab signaling
|
GO:0007249 |
85 |
0.016
|
|
|
|
mitotic sister chromatid cohesion
|
GO:0007064 |
1 |
0.016
|
|
|
|
negative regulation of hydrolase activity
|
GO:0051346 |
71 |
0.016
|
|
|
|
calcium ion homeostasis
|
GO:0055074 |
127 |
0.016
|
|
|
|
regulation of rho gtpase activity
|
GO:0032319 |
58 |
0.016
|
|
|
|
synaptic vesicle localization
|
GO:0097479 |
59 |
0.016
|
|
|
|
regulation of rho protein signal transduction
|
GO:0035023 |
71 |
0.016
|
|
|
|
skeletal system morphogenesis
|
GO:0048705 |
203 |
0.016
|
|
|
|
centrosome cycle
|
GO:0007098 |
23 |
0.016
|
|
|
|
peptidyl serine modification
|
GO:0018209 |
83 |
0.016
|
|
|
|
glycosyl compound catabolic process
|
GO:1901658 |
206 |
0.016
|
|
|
|
negative regulation of defense response
|
GO:0031348 |
77 |
0.016
|
|
|
|
divalent metal ion transport
|
GO:0070838 |
172 |
0.015
|
|
|
|
stress activated mapk cascade
|
GO:0051403 |
80 |
0.015
|
|
|
|
purine ribonucleoside catabolic process
|
GO:0046130 |
205 |
0.015
|
|
|
|
negative regulation of cell development
|
GO:0010721 |
169 |
0.015
|
|
|
|
establishment of protein localization to membrane
|
GO:0090150 |
54 |
0.015
|
|
|
|
positive regulation of cell projection organization
|
GO:0031346 |
95 |
0.015
|
|
|
|
neuronal action potential
|
GO:0019228 |
54 |
0.015
|
|
|
|
positive regulation of protein catabolic process
|
GO:0045732 |
60 |
0.015
|
|
|
|
establishment or maintenance of cell polarity
|
GO:0007163 |
86 |
0.015
|
|
|
|
convergent extension
|
GO:0060026 |
14 |
0.015
|
|
|
|
microtubule nucleation
|
GO:0007020 |
2 |
0.015
|
|
|
|
regulation of cell cycle phase transition
|
GO:1901987 |
77 |
0.015
|
|
|
|
regulation of cellular catabolic process
|
GO:0031329 |
242 |
0.015
|
|
|
|
hindbrain morphogenesis
|
GO:0021575 |
46 |
0.015
|
|
|
|
positive regulation of transcription elongation from rna polymerase ii promoter
|
GO:0032968 |
2 |
0.015
|
|
|
|
establishment of vesicle localization
|
GO:0051650 |
81 |
0.015
|
|
|
|
positive regulation of neuron projection development
|
GO:0010976 |
79 |
0.015
|
|
|
|
cell substrate junction assembly
|
GO:0007044 |
24 |
0.015
|
|
|
|
cell junction organization
|
GO:0034330 |
77 |
0.015
|
|
|
|
response to radiation
|
GO:0009314 |
165 |
0.015
|
|
|
|
regulation of ion transport
|
GO:0043269 |
215 |
0.015
|
|
|
|
cellular response to lipopolysaccharide
|
GO:0071222 |
77 |
0.014
|
|
|
|
cerebellum development
|
GO:0021549 |
77 |
0.014
|
|
|
|
regulation of protein transport
|
GO:0051223 |
163 |
0.014
|
|
|
|
regulation of protein catabolic process
|
GO:0042176 |
108 |
0.014
|
|
|
|
cell cell junction organization
|
GO:0045216 |
72 |
0.014
|
|
|
|
positive regulation of transferase activity
|
GO:0051347 |
167 |
0.014
|
|
|
|
regulation of protein maturation
|
GO:1903317 |
96 |
0.014
|
|
|
|
cell activation involved in immune response
|
GO:0002263 |
126 |
0.014
|
|
|
|
positive regulation of hydrolase activity
|
GO:0051345 |
148 |
0.014
|
|
|
|
negative regulation of leukocyte differentiation
|
GO:1902106 |
51 |
0.014
|
|
|
|
lymphocyte proliferation
|
GO:0046651 |
164 |
0.014
|
|
|
|
canonical wnt signaling pathway
|
GO:0060070 |
130 |
0.014
|
|
|
|
negative regulation of lymphocyte proliferation
|
GO:0050672 |
45 |
0.014
|
|
|
|
regulation of synaptic growth at neuromuscular junction
|
GO:0008582 |
4 |
0.014
|
|
|
|
positive regulation of purine nucleotide catabolic process
|
GO:0033123 |
88 |
0.014
|
|
|
|
rhythmic behavior
|
GO:0007622 |
15 |
0.014
|
|
|
|
positive regulation of proteolysis
|
GO:0045862 |
85 |
0.014
|
|
|
|
oogenesis
|
GO:0048477 |
56 |
0.014
|
|
|
|
synaptic vesicle transport
|
GO:0048489 |
57 |
0.014
|
|
|
|
synapse organization
|
GO:0050808 |
125 |
0.014
|
|
|
|
regulation of endocytosis
|
GO:0030100 |
69 |
0.014
|
|
|
|
muscle cell differentiation
|
GO:0042692 |
261 |
0.014
|
|
|
|
cellular response to molecule of bacterial origin
|
GO:0071219 |
83 |
0.014
|
|
|
|
regulation of leukocyte mediated immunity
|
GO:0002703 |
104 |
0.013
|
|
|
|
nucleoside monophosphate metabolic process
|
GO:0009123 |
85 |
0.013
|
|
|
|
regulation of multi organism process
|
GO:0043900 |
111 |
0.013
|
|
|
|
mrna metabolic process
|
GO:0016071 |
84 |
0.013
|
|
|
|
cation homeostasis
|
GO:0055080 |
212 |
0.013
|
|
|
|
negative regulation of proteolysis
|
GO:0045861 |
74 |
0.013
|
|
|
|
adherens junction assembly
|
GO:0034333 |
22 |
0.013
|
|
|
|
fat cell differentiation
|
GO:0045444 |
160 |
0.013
|
|
|
|
negative regulation of neuron differentiation
|
GO:0045665 |
101 |
0.013
|
|
|
|
positive regulation of cell cycle process
|
GO:0090068 |
61 |
0.013
|
|
|
|
transmembrane transport
|
GO:0055085 |
412 |
0.013
|
|
|
|
regulation of protein kinase activity
|
GO:0045859 |
232 |
0.013
|
|
|
|
myeloid cell homeostasis
|
GO:0002262 |
114 |
0.013
|
|
|
|
positive regulation of cellular protein catabolic process
|
GO:1903364 |
34 |
0.013
|
|
|
|
positive regulation of neuron differentiation
|
GO:0045666 |
141 |
0.013
|
|
|
|
histone monoubiquitination
|
GO:0010390 |
3 |
0.013
|
|
|
|
receptor mediated endocytosis
|
GO:0006898 |
51 |
0.013
|
|
|
|
cilium morphogenesis
|
GO:0060271 |
102 |
0.013
|
|
|
|
dna integrity checkpoint
|
GO:0031570 |
28 |
0.013
|
|
|
|
circadian behavior
|
GO:0048512 |
13 |
0.013
|
|
|
|
adherens junction organization
|
GO:0034332 |
28 |
0.013
|
|
|
|
sensory perception
|
GO:0007600 |
245 |
0.013
|
|
|
|
protein localization to nucleus
|
GO:0034504 |
121 |
0.013
|
|
|
|
golgi vesicle transport
|
GO:0048193 |
30 |
0.012
|
|
|
|
protein import into nucleus
|
GO:0006606 |
95 |
0.012
|
|
|
|
spindle assembly involved in female meiosis
|
GO:0007056 |
3 |
0.012
|
|
|
|
regulation of gtp catabolic process
|
GO:0033124 |
113 |
0.012
|
|
|
|
dna recombination
|
GO:0006310 |
92 |
0.012
|
|
|
|
regulation of genetic imprinting
|
GO:2000653 |
5 |
0.012
|
|
|
|
cerebellar cortex development
|
GO:0021695 |
48 |
0.012
|
|
|
|
negative regulation of wnt signaling pathway
|
GO:0030178 |
73 |
0.012
|
|
|
|
response to oxidative stress
|
GO:0006979 |
123 |
0.012
|
|
|
|
regulation of extrinsic apoptotic signaling pathway
|
GO:2001236 |
77 |
0.012
|
|
|
|
regulation of leukocyte proliferation
|
GO:0070663 |
121 |
0.012
|
|
|
|
peptidyl lysine methylation
|
GO:0018022 |
29 |
0.012
|
|
|
|
cytokine production
|
GO:0001816 |
319 |
0.012
|
|
|
|
cytoskeleton dependent intracellular transport
|
GO:0030705 |
50 |
0.012
|
|
|
|
jnk cascade
|
GO:0007254 |
72 |
0.012
|
|
|
|
central nervous system neuron differentiation
|
GO:0021953 |
162 |
0.012
|
|
|
|
cell recognition
|
GO:0008037 |
83 |
0.012
|
|
|
|
regulation of actin filament length
|
GO:0030832 |
45 |
0.012
|
|
|
|
negative regulation of protein modification process
|
GO:0031400 |
163 |
0.012
|
Human |
|
|
sequestering of calcium ion
|
GO:0051208 |
18 |
0.012
|
|
|
|
plasma membrane organization
|
GO:0007009 |
90 |
0.012
|
|
|
|
female gamete generation
|
GO:0007292 |
74 |
0.012
|
|
|
|
action potential
|
GO:0001508 |
78 |
0.012
|
|
|
|
negative regulation of t cell proliferation
|
GO:0042130 |
38 |
0.012
|
|
|
|
inorganic ion transmembrane transport
|
GO:0098660 |
234 |
0.012
|
|
|
|
gtp catabolic process
|
GO:0006184 |
143 |
0.012
|
|
|
|
synaptic transmission
|
GO:0007268 |
329 |
0.012
|
|
|
|
demethylation
|
GO:0070988 |
23 |
0.012
|
|
|
|
muscle tissue development
|
GO:0060537 |
308 |
0.012
|
|
|
|
regulation of mitotic cell cycle phase transition
|
GO:1901990 |
73 |
0.012
|
|
|
|
regulation of microtubule based process
|
GO:0032886 |
52 |
0.011
|
|
|
|
positive regulation of cell cycle
|
GO:0045787 |
92 |
0.011
|
|
|
|
cellular lipid metabolic process
|
GO:0044255 |
323 |
0.011
|
|
|
|
b cell activation
|
GO:0042113 |
161 |
0.011
|
|
|
|
establishment or maintenance of cytoskeleton polarity
|
GO:0030952 |
2 |
0.011
|
|
|
|
regulation of cellular protein catabolic process
|
GO:1903362 |
61 |
0.011
|
|
|
|
embryonic body morphogenesis
|
GO:0010172 |
10 |
0.011
|
|
|
|
regulation of organelle assembly
|
GO:1902115 |
19 |
0.011
|
|
|
|
peptidyl serine phosphorylation
|
GO:0018105 |
74 |
0.011
|
|
|
|
establishment of synaptic vesicle localization
|
GO:0097480 |
57 |
0.011
|
|
|
|
negative regulation of mitotic cell cycle
|
GO:0045930 |
58 |
0.011
|
|
|
|
negative regulation of epithelial cell proliferation
|
GO:0050680 |
64 |
0.011
|
|
|
|
regulation of neuron death
|
GO:1901214 |
134 |
0.011
|
|
|
|
skin development
|
GO:0043588 |
220 |
0.011
|
|
|
|
regulation of purine nucleotide metabolic process
|
GO:1900542 |
169 |
0.011
|
|
|
|
alpha beta t cell activation
|
GO:0046631 |
91 |
0.011
|
|
|
|
positive regulation of potassium ion transport
|
GO:0043268 |
3 |
0.011
|
|
|
|
renal system development
|
GO:0072001 |
225 |
0.011
|
|
|
|
negative regulation of peptidase activity
|
GO:0010466 |
46 |
0.011
|
|
|
|
atp catabolic process
|
GO:0006200 |
55 |
0.011
|
|
|
|
jak stat cascade
|
GO:0007259 |
42 |
0.011
|
|
|
|
negative regulation of apoptotic signaling pathway
|
GO:2001234 |
104 |
0.011
|
|
|
|
positive regulation of lymphocyte activation
|
GO:0051251 |
140 |
0.011
|
|
|
|
purine nucleoside monophosphate metabolic process
|
GO:0009126 |
81 |
0.011
|
|
|
|
regulation of proteasomal protein catabolic process
|
GO:0061136 |
46 |
0.011
|
|
|
|
positive regulation of cell activation
|
GO:0050867 |
158 |
0.011
|
|
|
|
intrinsic apoptotic signaling pathway in response to dna damage
|
GO:0008630 |
57 |
0.011
|
|
|
|
blastocyst formation
|
GO:0001825 |
33 |
0.011
|
|
|
|
response to molecule of bacterial origin
|
GO:0002237 |
143 |
0.011
|
|
|
|
multi multicellular organism process
|
GO:0044706 |
109 |
0.011
|
|
|
|
regulation of dendritic cell cytokine production
|
GO:0002730 |
2 |
0.011
|
|
|
|
negative regulation of transmembrane receptor protein serine threonine kinase signaling pathway
|
GO:0090101 |
61 |
0.011
|
|
